Home LiteratureArticle Details
PMID: 10913039 Published · ppublish English Journal Article

The mineralocorticoid receptor mediates aldosterone-induced differentiation of T37i cells into brown adipocytes.

American journal of physiology. Endocrinology and metabolism ·Vol. 279 ·No. 2 ·2000-08-00 ·Pages E386-94

Penfornis P, Viengchareun S, Le Menuet D, Cluzeaud F, Zennaro MC, Lombès M

Abstract

By use of targeted oncogenesis, a brown adipocyte cell line was derived from a hibernoma of a transgenic mouse carrying the proximal promoter of the human mineralocorticoid receptor (MR) linked to the SV40 large T antigen. T37i cells remain capable of differentiating into brown adipocytes upon insulin and triiodothyronine treatment as judged by their ability to express uncoupling protein 1 and maintain MR expression. Aldosterone treatment of undifferentiated cells induced accumulation of intracytoplasmic lipid droplets and mitochondria. This effect was accompanied by a significant and dose-dependent increase in intracellular triglyceride content (half-maximally effective dose 10(-9) M) and involved MR, because it was unaffected by RU-38486 treatment but was totally abolished in the presence of aldosterone antagonists (spironolactone, RU-26752). The expression of early adipogenic gene markers, such as lipoprotein lipase, peroxisome proliferator-activated receptor-gamma, and adipocyte-specific fatty acid binding protein 2, was enhanced by aldosterone, confirming activation of the differentiation process. We demonstrate that, in the T37i cell line, aldosterone participates in the very early induction of brown adipocyte differentiation. Our findings may have a broader biological significance and suggest that MR is not only implicated in maintaining electrolyte homeostasis but could also play a role in metabolism and energy balance.

MeSH Terms
Adipose Tissue, Brown/metabolism,pathology Aldosterone/pharmacology Animals Carrier Proteins/genetics,metabolism Cell Differentiation/drug effects,physiology Dose-Response Relationship, Drug Fatty Acid-Binding Protein 7 Fatty Acid-Binding Proteins Hormone Antagonists/pharmacology Lipoma/metabolism,pathology,ultrastructure Lipoprotein Lipase/genetics,metabolism Mice Mifepristone/pharmacology Mineralocorticoid Receptor Antagonists/pharmacology Myelin P2 Protein/genetics,metabolism Neoplasm Proteins Nerve Tissue Proteins RNA, Messenger/biosynthesis Receptors, Cytoplasmic and Nuclear/genetics,metabolism Receptors, Mineralocorticoid/metabolism Spironolactone/analogs & derivatives,pharmacology Transcription Factors/genetics,metabolism Transcription, Genetic/drug effects Triglycerides/metabolism Tumor Cells, Cultured
Chemicals
Carrier Proteins Fabp5 protein, mouse Fabp7 protein, mouse Fatty Acid-Binding Protein 7 Fatty Acid-Binding Proteins Hormone Antagonists Mineralocorticoid Receptor Antagonists Myelin P2 Protein Neoplasm Proteins Nerve Tissue Proteins RNA, Messenger Receptors, Cytoplasmic and Nuclear Receptors, Mineralocorticoid Transcription Factors Triglycerides Spironolactone Mifepristone Aldosterone 7-propyl spirolactone Lipoprotein Lipase
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Penfornis P
Institut National de la Santé et de la Recherche Médicale U 478, Faculté de Médecine Xavier Bichat, 75870 Paris, France.
Viengchareun S
Le Menuet D
Cluzeaud F
Zennaro M C
Lombès M
Article Info
Journal
American journal of physiology. Endocrinology and metabolism
Abbr.
Am J Physiol Endocrinol Metab
ISSN
0193-1849
Published
2000-08-00
Pages
E386-94
Language
English
Region
United States
NLM ID
100901226
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com